New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine
Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline glioma in Science Advances.HEIDELBERG, GERMANY / ACCESSWIRE / February 6, 20…